Product Description
Aspartame is an artificial sweetener, sold under brand names such as NutraSweet® and Equal®, that has been in use in the United States since the early 1980s. It is used in many foods and beverages because it is much sweeter than sugar, so much less of it can be used to give the same level of sweetness. (Sourced from: https://www.cancer.org/healthy/cancer-causes/chemicals/aspartame.html)
Mechanisms of Action: No Mechanism
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: Oral
FDA Designation: None *
Approval Status: Not Approved
Approved Countries: Bangladesh | Chile | Colombia | Ecuador | Malta | Peru | Russia | Slovenia | South Africa | Turkey | Venezuela | Vietnam
Approved Indications: None
Known Adverse Events: None
Company: University of California, Davis
Company Location:
Company CEO:
Additonal Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Highest Development Phases
Phase 2: Xerostomia|Sjogren's Syndrome|Body Weight Changes
Phase 1: Amyotrophic Lateral Sclerosis
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
|---|---|---|---|---|---|
| ChiCTR2400086648 | N/A |
Recruiting |
Atherosclerosis |
2025-12-31 |
|
| ACTRN12623000099628 | N/A |
Not yet recruiting |
Obesity|Type 2 Diabetes |
2025-03-01 |
|
| ADOB | N/A |
Recruiting |
Weight Gain|Pediatric Obesity |
2024-09-01 |
|
| ACTRN12620000970943 | N/A |
Recruiting |
Type 2 Diabetes |
2021-12-15 |